Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
6.35
-0.34 (-5.08%)
At close: Aug 13, 2025, 4:00 PM
6.40
+0.09 (1.43%)
Pre-market: Aug 14, 2025, 8:52 AM EDT
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $249.98 million as of August 14, 2025. Its market cap has decreased by -11.15% in one year.
Market Cap
249.98M
Enterprise Value
202.00M
1-Year Change
-11.15%
Ranking
Category
Stock Price
$6.35
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $249.98M, a decrease of -50.61%. That is a compound annual growth rate of -14.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 249.98M | -21.90% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 570.26B |
| Johnson & Johnson | 418.62B |
| AbbVie | 350.91B |
| AstraZeneca | 229.47B |
| UnitedHealth Group | 228.94B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 228.63B |
| Novo Nordisk | 222.88B |